Tesla must hold above $434.61 to keep momentum toward $453+ intraday.
1 extracted signal · 1 resolved · 0 still active
Wicked Stocks10 Oct 2025, 15:49 UTC
AI-generated source summary
The analysis projects a potential delay to the long-term objective of $524.64, estimating 3 to 5 months to reach that target. The stock settled above the $362.39 channel top a month ago, and after testing the seven-month channel top it's susceptible to falling back to the $362.39 region in the coming weeks. A rising channel top at $406.13 acts as a weekly support area. The market should see $406.13 tested in the next 3-5 days. A close today above $453.25 would retest $465.99 in 1-2 days. $465.99 is the beginning of a range up to $469.54, that can contain buying through November. Holding below $434.61 can yield $406.13. A downside play is a 1-2 month window.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from Wicked Stocks
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 31st, 2026
#TSLA MAY BOUNCE FIRST... THEN FALL TO $227 #Tesla #daytrading
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 30th, 2026
#TSLA BOUNCED FROM $300... BUT IS IT A TRAP? #Tesla #daytrading
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 29th, 2026
#TSLA $300 TEST IS ALMOST HERE #Tesla #daytrading
Wicked Stocks
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
